Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals
Clinical Benefit
| Substantial |
Le service médical rendu par COSOPT 20 mg/5 ml/ml, collyre en solution en récipient unidose, est important.
|
Clinical Added Value
| no clinical added value |
COSOPT 20 mg/5 mg/ml, collyre en solution en récipient unidose, n'apporte pas d'amélioration du service médical rendu (niveau V) par rapport COSOPT, collyre en solution en flacon multidose.
|
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
j9XwQJYvJyZuF7Q8
